VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $0 | -100.0% | 10 | -95.1% | 0.00% | – |
Q4 2017 | $4,000 | -50.0% | 205 | -62.5% | 0.00% | – |
Q3 2017 | $8,000 | +700.0% | 546 | +1087.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | -75.0% | 46 | -74.6% | 0.00% | – |
Q3 2016 | $4,000 | -20.0% | 181 | -21.6% | 0.00% | – |
Q2 2016 | $5,000 | -37.5% | 231 | -26.9% | 0.00% | – |
Q1 2016 | $8,000 | -38.5% | 316 | +156.9% | 0.00% | – |
Q4 2015 | $13,000 | -98.4% | 123 | -97.3% | 0.00% | -100.0% |
Q3 2015 | $812,000 | +2.1% | 4,551 | +27.2% | 0.01% | +14.3% |
Q2 2015 | $795,000 | +12.9% | 3,577 | +1.0% | 0.01% | +16.7% |
Q1 2015 | $704,000 | +270.5% | 3,542 | +167.1% | 0.01% | +200.0% |
Q4 2014 | $190,000 | +900.0% | 1,326 | +808.2% | 0.00% | – |
Q3 2014 | $19,000 | +46.2% | 146 | +41.7% | 0.00% | – |
Q2 2014 | $13,000 | -96.0% | 103 | -95.8% | 0.00% | -100.0% |
Q1 2014 | $324,000 | -4.7% | 2,455 | -15.2% | 0.00% | 0.0% |
Q4 2013 | $340,000 | +67.5% | 2,896 | +48.9% | 0.00% | +50.0% |
Q3 2013 | $203,000 | +680.8% | 1,945 | +548.3% | 0.00% | – |
Q2 2013 | $26,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |